Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,491 | -4,816 | -44,303 | -23,900 | -19,716 |
| Depreciation Amortization | 58 | 26 | 1,223 | 1,136 | 789 |
| Accounts receivable | -11 | -11 | 12 | 9 | 2 |
| Accounts payable and accrued liabilities | 327 | 163 | -68 | 6 | -21 |
| Other Working Capital | 300 | 41 | 325 | 541 | 311 |
| Other Operating Activity | 5,972 | 3,003 | 39,482 | 20,023 | 17,080 |
| Operating Cash Flow | $-2,846 | $-1,595 | $-3,330 | $-2,185 | $-1,556 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -247 | -110 | -31 | N/A | N/A |
| Investing Cash Flow | $-247 | $-110 | $-31 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 250 | 250 | 250 |
| Common Stock Issued | N/A | N/A | 21,073 | N/A | N/A |
| Financing Cash Flow | $N/A | $N/A | $21,323 | $250 | $250 |
| Beginning Cash Position | 21,027 | 21,027 | 3,065 | 3,065 | 3,065 |
| End Cash Position | 17,934 | 19,323 | 21,027 | 1,130 | 1,759 |
| Net Cash Flow | $-3,093 | $-1,704 | $17,962 | $-1,935 | $-1,306 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,846 | -1,595 | -3,330 | -2,185 | -1,556 |
| Capital Expenditure | -247 | -110 | -31 | N/A | N/A |
| Free Cash Flow | -3,093 | -1,704 | -3,361 | -2,185 | -1,556 |